Allium stent for the treatment of a malignant ureteral stenosis: A paradigmatic case

Urologia. 2018 May;85(2):87-90. doi: 10.5301/uj.5000249. Epub 2017 Jun 14.

Abstract

Objective: The aim of this study was to present a paradigmatic case where the new-generation Allium URS stent was the optimal choice to treat a malignant ureteral stenosis.

Methods: We describe in detail all the steps of our surgery, performed on a 69-year-old patient with left hydronephrosis caused by lumbo-aortic nodal metastases compressing the ureter. The patient was intolerant to double-J stent due to strong irritative urinary symptoms. Allium URS stent was positioned under fluoroscopy in replacement of pre-existing double-J stent.

Results: Our approach was successful and irritative urinary symptoms disappeared. At 6 months, the Allium URS was correctly positioned and no hydronephrosis was detected on ultrasound. The stent can be left in place for a maximum of 3 years.

Conclusions: In complicated scenarios of chronic ureteral stenosis, the new-generation Allium URS can be an interesting option to treat the obstruction while sparing the patient the irritative urinary symptoms and periodic replacements typical of a double-J stent.

Keywords: Allium; Nitinol; Ureteral stenosis; Ureteral stent.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Humans
  • Lymphatic Metastasis
  • Prosthesis Design
  • Stents*
  • Ureteral Obstruction / etiology
  • Ureteral Obstruction / surgery*